Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) has announced a special window for the re-lodgement of transfer requests for physical shares. This facility is available from July 07, 2025, to January 06, 2026. It is intended for shareholders who had lodged transfer requests for physical shares prior to the April 01, 2019 deadline, but which were rejected, returned, or not attended to due to deficiencies in documentation or process. Shareholders wishing to utilize this opportunity are advised to contact the Company's Registrar and Share Transfer Agent, KFin Technologies Limited, at einward.ris@kfintech.com or call 1800-309-4001. The unit handling this is Cohance Lifesciences Limited, located at Selenium Tower B, Plot 31-32, Financial District, Nanakramguda, Serilingampally Mandal, Hyderabad-500 032. This notice is issued in compliance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 2, 2025. The announcement also mentions that the company has published newspaper advertisements regarding this special window in Business Standard (English Daily) and Navshakti (Marathi Daily) on December 27, 2025. This information will also be available on the company's website at https://www.cohance.com/corporate-info/.